Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Validation of a simplified international prognostic score (IPS‐3) in patients with advanced‐stage classic Hodgkin lymphoma.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Hayden, Anna R.; Lee, Derrick G.; Villa, Diego; Gerrie, Alina S.; Scott, David W.; Slack, Graham W.; Sehn, Laurie H.; Connors, Joseph M.; Savage, Kerry J.
- Source:
British Journal of Haematology; Apr2020, Vol. 189 Issue 1, p122-127, 6p, 1 Chart, 3 Graphs
- Subject Terms:
- Additional Information
- Subject Terms:
- Abstract:
Summary: A novel prognostic score (IPS‐3), comprised of only three of the seven IPS‐7 indicators (age ≥45, stage IV, haemoglobin <105 g/l), was recently proposed as a simplified model for advanced‐stage classic Hodgkin lymphoma (cHL). We aimed to validate this model in advanced‐stage cHL patients treated with doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) in British Columbia. The estimated five‐year freedom from progression (FFP) for scores of 0, 1, 2 and 3 were very similar to the original report at 84%, 76%, 72% and 68% respectively. The IPS‐3 score is highly reproducible in this independent dataset and its simplicity makes it appealing for everyday clinical practice. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of British Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.